|
Sign In to gain access to subscriptions and/or personal tools.
|
Antibodies to oxidised LDL
O Vaarala
Department of Biochemistry, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland Tel: (+ 358) 9 4744 8463; Fax: (+ 358)9 4744 8281; outi.vaarala{at}ktl.fi
In prospective studies antibodies to oxidised LDL (low density lipoprotein) have been shown to predict myocardial infarction and progression of carotid athesclerosis in non-autoimmune subjects. The antibodies to oxidised LDL are crossreactive with antiphospholipid antibodies most likely due to their binding to oxidised phospholipids. The frequent occurrence of these antibodies and their association with arterial thrombosis in patients with SLE and antiphospholipid syndrome suggest their involvement in the development of accelerated atherosclerosis in these patients. Some in vitro studies suggest that antibodies to oxidised LDL may have an atherogenic effect by enhancing the lipid accumulation into macrophages in the atherosclerotic vessels. These antibodies can be considered as markers of the pathogenic determinants of atherosclerosis, such as enhanced lipid oxidation, proinflammatory stage and impaired vasodilatation.
Key Words: oxidisedLDL • cardiolipin • atherosclerosis • antiphospholipidsyndrome • SLE
Lupus, Vol. 9, No. 3,
202-205 (2000)
DOI: 10.1191/096120300678828280
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Brandlein, N. Rauschert, L. Rasche, A. Dreykluft, F. Hensel, E. Conzelmann, H.-K. Muller-Hermelink, and H. P. Vollmers
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein
Mol. Cancer Ther.,
January 1, 2007;
6(1):
326 - 333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R J Davies, S R Sangle, M A Khamashta, and D P D'Cruz
Antiphospholipid (Hughes) syndrome and atheroma
Lupus,
November 1, 2006;
15(11_suppl):
55 - 58.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke,
July 1, 2006;
37(7):
1923 - 1932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tedgui
The role of inflammation in atherothrombosis: implications for clinical practice
Vascular Medicine,
February 1, 2005;
10(1):
45 - 53.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M.-K. Chang, C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum
Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory
J. Exp. Med.,
December 6, 2004;
200(11):
1359 - 1370.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Delgado Alves, S. Kumar, and D. A. Isenberg
Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
Rheumatology,
July 1, 2003;
42(7):
893 - 899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Nuttall, S. Heaton, M. K. Piper, U. Martin, and C. Gordon
Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia
Rheumatology,
June 1, 2003;
42(6):
758 - 762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Osula, G M Bell, and R S Hornung
Acute myocardial infarction in young adults: causes and management
Postgrad. Med. J.,
January 1, 2002;
78(915):
27 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Schenkein, C. R. Berry, D. Purkall, J. A. Burmeister, C. N. Brooks, and J. G. Tew
Phosphorylcholine-Dependent Cross-Reactivity between Dental Plaque Bacteria and Oxidized Low-Density Lipoproteins
Infect. Immun.,
November 1, 2001;
69(11):
6612 - 6617.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
